Baijin Life Science Holdings Limited (HKG:1466)
0.530
-0.020 (-3.64%)
Mar 10, 2026, 1:19 PM HKT
HKG:1466 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | 8.08 | -0.32 | -7.45 | 8.68 | -15.46 | -51.79 | Upgrade
|
| Depreciation & Amortization | 6.32 | 6.66 | 1.93 | 1.43 | 1.36 | 2.18 | Upgrade
|
| Other Amortization | -0.72 | -0.72 | 2.28 | - | - | 1.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.05 | -4.05 | - | - | -0.51 | -0.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20.03 | 20.03 | 0.2 | - | 0 | 1.27 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 4.71 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | - | 0.03 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.87 | -1.56 | -0.4 | -4.88 | -4.53 | 12.91 | Upgrade
|
| Other Operating Activities | -34.81 | -16.46 | -18 | -25.34 | 16.1 | 14.4 | Upgrade
|
| Change in Accounts Receivable | 2.01 | -21.98 | -2.23 | 3.67 | 3.04 | 14.91 | Upgrade
|
| Change in Inventory | -13.2 | -18.27 | 15.23 | -9.43 | -0.52 | -1.25 | Upgrade
|
| Change in Accounts Payable | -1.89 | 7.85 | -1.36 | 4.37 | 1.64 | -19.05 | Upgrade
|
| Change in Unearned Revenue | 1.64 | -1.71 | 3.35 | - | - | - | Upgrade
|
| Operating Cash Flow | -18.46 | -30.53 | -6.46 | -21.52 | 1.11 | -16.18 | Upgrade
|
| Capital Expenditures | -2.16 | -2.45 | -0.18 | -0.03 | -0.05 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.16 | Upgrade
|
| Cash Acquisitions | - | - | 3.6 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -0.02 | - | Upgrade
|
| Other Investing Activities | 1.31 | 1.6 | 1.32 | 0.22 | 0.01 | 0.01 | Upgrade
|
| Investing Cash Flow | -0.86 | -0.85 | 4.74 | 35.3 | -0.06 | 0.14 | Upgrade
|
| Short-Term Debt Issued | - | 8.56 | 2.22 | 2 | 0.02 | 28 | Upgrade
|
| Total Debt Issued | 13.47 | 8.56 | 2.22 | 2 | 0.02 | 28 | Upgrade
|
| Short-Term Debt Repaid | - | -5.42 | - | -29.78 | -3 | -29.29 | Upgrade
|
| Long-Term Debt Repaid | - | -0.98 | -1.14 | -1.23 | -0.68 | -1.25 | Upgrade
|
| Total Debt Repaid | -13.62 | -6.4 | -1.14 | -31.01 | -3.68 | -30.54 | Upgrade
|
| Net Debt Issued (Repaid) | -0.15 | 2.16 | 1.07 | -29.01 | -3.66 | -2.54 | Upgrade
|
| Issuance of Common Stock | 31.17 | 40.22 | - | 32.77 | 5.23 | 14.4 | Upgrade
|
| Other Financing Activities | -1.13 | -0.97 | -0.25 | -0.07 | -3.29 | -5.09 | Upgrade
|
| Financing Cash Flow | 29.89 | 41.41 | 0.82 | 3.7 | -1.72 | 6.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.52 | -0.15 | -2.48 | 0.2 | -0.17 | -0.8 | Upgrade
|
| Net Cash Flow | 13.09 | 9.89 | -3.38 | 17.68 | -0.84 | -10.07 | Upgrade
|
| Free Cash Flow | -20.63 | -32.97 | -6.64 | -21.55 | 1.06 | -16.21 | Upgrade
|
| Free Cash Flow Margin | -17.22% | -24.32% | -12.36% | -24.80% | 1.70% | -37.41% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.05 | -0.01 | -0.04 | 0.00 | -0.07 | Upgrade
|
| Cash Interest Paid | 1.13 | 0.97 | 0.25 | 0.07 | 3.29 | 4.4 | Upgrade
|
| Cash Income Tax Paid | 1.2 | 0.25 | 0.02 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -79.53 | -82.41 | -15.69 | 1.36 | 8.58 | -4.68 | Upgrade
|
| Unlevered Free Cash Flow | -79.05 | -81.81 | -15.51 | 2 | 11.32 | -1.9 | Upgrade
|
| Change in Working Capital | -11.44 | -34.12 | 14.99 | -1.4 | 4.15 | -5.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.